Meta-analysis shows reductions in death anxiety with psychedelic experiences, suggesting therapeutic potential for end-of-life care.
This meta-analysis and systematic review examined the effects of psychedelic substances on death anxiety, specifically evaluating whether psychedelic experiences are associated with statistically significant reductions in death anxiety. A systematic search identified 8 studies suitable for meta-analysis and 10 additional studies for systematic review. Using a random-effects model, the meta-analysis revealed a significant overall effect (Cohen's d = 0.70; 95% confidence interval [0.42, 0.97]), indicating a moderate-to-large reduction in death anxiety following psychedelic administration. Subgroup analyses showed stronger effects in clinically controlled settings compared to the general population. A mixed-effects meta-regression also indicated that particularly mystical experiences were positively associated with reductions in death anxiety (B = 4.90, p = 0.050). Moderator effects by substance type were not significant. The qualitative review reaffirmed these results and identified themes of ego dissolution, emotional catharsis, and living in the present moment. Psychedelic-assisted interventions may be effective for reducing death anxiety, particularly in end-of-life care. However, limitations include a small number of studies, potential publication bias, and high heterogeneity in outcome measurement. Future research should employ more methodologically rigorous trials in order to clarify the mechanisms of psychedelic-assisted approaches to death anxiety.
No takes yet. Share an insight, caveat, or question.
Cohorst et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: